For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.

Olomouc 77900

0 studies enrolling now · 4 studies all time

What they study most

Gastroesophageal Junction Adenocarcinoma, Major Depressive Disorder (MDD), Metastatic Gastric Adenocarcinoma, Non Hodgkin Lymphoma, Sepsis

Studies at this site

• A Study of Ramucirumab (LY3009806) in Combination With Capecitabine and Cisplatin in Participants With Stomach Cancer — Completed
• PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin — Completed
• A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment — Completed
• Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock — Completed